Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes
Bo Yuan, … , Richard A. Gibbs, James R. Lupski
Bo Yuan, … , Richard A. Gibbs, James R. Lupski
Published January 9, 2015
Citation Information: J Clin Invest. 2015;125(2):636-651. https://doi.org/10.1172/JCI77435.
View: Text | PDF
Research Article Genetics

Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes

  • Text
  • PDF
Abstract

Cornelia de Lange syndrome (CdLS) is a genetically heterogeneous disorder that presents with extensive phenotypic variability, including facial dysmorphism, developmental delay/intellectual disability (DD/ID), abnormal extremities, and hirsutism. About 65% of patients harbor mutations in genes that encode subunits or regulators of the cohesin complex, including NIPBL, SMC1A, SMC3, RAD21, and HDAC8. Wiedemann-Steiner syndrome (WDSTS), which shares CdLS phenotypic features, is caused by mutations in lysine-specific methyltransferase 2A (KMT2A). Here, we performed whole-exome sequencing (WES) of 2 male siblings clinically diagnosed with WDSTS; this revealed a hemizygous, missense mutation in SMC1A that was predicted to be deleterious. Extensive clinical evaluation and WES of 32 Turkish patients clinically diagnosed with CdLS revealed the presence of a de novo heterozygous nonsense KMT2A mutation in 1 patient without characteristic WDSTS features. We also identified de novo heterozygous mutations in SMC3 or SMC1A that affected RNA splicing in 2 independent patients with combined CdLS and WDSTS features. Furthermore, in families from 2 separate world populations segregating an autosomal-recessive disorder with CdLS-like features, we identified homozygous mutations in TAF6, which encodes a core transcriptional regulatory pathway component. Together, our data, along with recent transcriptome studies, suggest that CdLS and related phenotypes may be “transcriptomopathies” rather than cohesinopathies.

Authors

Bo Yuan, Davut Pehlivan, Ender Karaca, Nisha Patel, Wu-Lin Charng, Tomasz Gambin, Claudia Gonzaga-Jauregui, V. Reid Sutton, Gozde Yesil, Sevcan Tug Bozdogan, Tulay Tos, Asuman Koparir, Erkan Koparir, Christine R. Beck, Shen Gu, Huseyin Aslan, Ozge Ozalp Yuregir, Khalid Al Rubeaan, Dhekra Alnaqeb, Muneera J. Alshammari, Yavuz Bayram, Mehmed M. Atik, Hatip Aydin, B. Bilge Geckinli, Mehmet Seven, Hakan Ulucan, Elif Fenercioglu, Mustafa Ozen, Shalini Jhangiani, Donna M. Muzny, Eric Boerwinkle, Beyhan Tuysuz, Fowzan S. Alkuraya, Richard A. Gibbs, James R. Lupski

×

Figure 2

The variants in SMC1A and SYCP2 identified in the patients with WDSTS (WDSTS-1 and WDSTS-2).

Options: View larger image (or click on image) Download as PowerPoint
The variants in SMC1A and SYCP2 identified in the patients with WDSTS (W...
(A) Pedigree of the family and the Sanger-sequencing chromatogram showing the segregation analysis of variants identified in SMC1A and SYCP2. The blue shading in the chromatograms marks the position of the variants. The genes and nt changes are shown underneath the chromatograms. (B) Peptide alignments showing the conservation of the affected aa across different species. First panel: Leu41 in SMC1A. Second panel: Ile951 in SYCP2. All these aa are highlighted by yellow shading, and they are highly conserved across the species. (C) The B-allele frequency plots from the WES data of WDSTS-1. The upper panel shows the overall B-allele frequencies of the entire chromosome 20. The lower panel shows the zoomed-in view of the region surrounding the variant (Chr20: g.58455447 A>G [hg19]). The region highlighted by red shading represents the AOH region, including the gene SYCP2, which is indicated by the black arrow. (D) The interaction network that includes both SC and the cohesin complex. Blue hexagons, major components of the SC; red circles, major components of the cohesin complex; gray squares, other interacting partners involved in this network. Heavy black lines show the strong interactions between the SYCP2 and the 3 major components of the cohesin complex: SMC1A, SMC3, and RAD21.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts